| Bioactivity | Rifasutenizol (TNP-2198) is a potent and orally bioavailable dual-targeted antibacterial agent. Rifasutenizol has potent activity against microaerophilic and anaerobic bacterial pathogens[1]. |
| Invitro | Rifasutenizol exhibits potent bactericidal activity against key microaerophilic and anaerobic bacterial pathogens, including Helicobacter pylori, Clostridioides difficile, and Gardnerella vaginalis, including rifamycin-resistant and nitroimidazole-resistant strains[1]. |
| Name | Rifasutenizol |
| CAS | 1001314-13-1 |
| Formula | C48H61N7O13 |
| Molar Mass | 944.04 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ma Z, et al. Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens. J Med Chem. 2022;65(6):4481-4495. |
Rifasutenizol
CAS: 1001314-13-1 F: C48H61N7O13 W: 944.04
Rifasutenizol (TNP-2198) is a potent and orally bioavailable dual-targeted antibacterial agent. Rifasutenizol has potent
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.